Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial: A randomized trial of IV iron in critical illness

Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial: A randomized trial of IV iron in critical illness

Purpose: Both anaemia and allogenic red blood cell transfusion are common and potentially harmful in patients admitted to the intensive care unit. Whilst intravenous iron may decrease anaemia and RBC transfusion requirement, the safety and efficacy of administering iron intravenously to critically i...

Full description

Bibliographic Details
Main Authors: The, I., Litton, E., Baker, S., Erber, W., Farmer, Shannon, Ferrier, J., French, C., Gummer, J., Hawkins, D., Higgins, A., Hofmann, Axel, De Keulenaer, B., McMorrow, J., Olynyk, John, Richards, T., Towler, S., Trengove, R., Webb, S., The, A.
Format: Journal Article
Published: Springer-Verlag 2016
Online Access:http://hdl.handle.net/20.500.11937/58413

Internet

http://hdl.handle.net/20.500.11937/58413

Similar Items